Press Release Jul 23 2024
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release announcing that it received final approval from the USFDA for Valsartan Tablets. The tablets are indicated for treating hypertension and heart failure in adults and pediatric patients. The drug will be manufactured at the company's facility in Ahmedabad SEZ - II, India.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jul 22 2024
- Press Release Jul 19 2024
- Press Release Jul 17 2024
- Press Release (Revised) Jul 10 2024
- Press Release Jul 10 2024
Later from Zydus Lifesciences
- Press Release Jul 31 2024
- Press Release Aug 09 2024
- Press Release Aug 23 2024
- Press Release Aug 27 2024
- Press Release Aug 30 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences